» Articles » PMID: 22270133

Validation of the Comprehensive International Classification of Functioning, Disability, and Health Core Set for Multiple Sclerosis from the Perspective of Physicians

Overview
Journal J Neurol
Specialty Neurology
Date 2012 Jan 25
PMID 22270133
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The Comprehensive International Classification of Functioning, Disability and Health (ICF) Core Set for multiple sclerosis (MS) is an application of the ICF to describe the typical spectrum of functioning in people with MS. The objective of this study was to validate the Comprehensive ICF Core Set for MS from the perspective of physicians. Using a three-round Delphi technique, physicians experienced in the MS treatment were requested to name patients' problems, resources, and aspects of environment. The statements of the first Delphi round were linked to ICF categories based on established linking rules. These categories as well as the results of the second round were reported back to the participants. Eighty-four physicians participated in the study. Totally, 89 categories (64.5%) of the Comprehensive ICF Core Set for MS were confirmed by the participants. Eight ICF categories, which are currently not included in the ICF Core Set, were identified. The validity of the Comprehensive ICF Core Set for MS was largely affirmed by the physicians. However, some additional categories were named, which should be further discussed regarding a revised version of the Comprehensive ICF Core Set for MS.

Citing Articles

Can International Classification of Functioning, Disability and Health (ICF) Be Used for Prediction of Work Capacity and Employment Status in Multiple Sclerosis?.

Valadkeviciene D, Jatuzis D, Zukauskaite I, Bileviciute-Ljungar I J Clin Med. 2024; 13(14).

PMID: 39064236 PMC: 11277909. DOI: 10.3390/jcm13144195.


Revision of the brief international classification of functioning, disability and health core set for multiple sclerosis: a study of the comprehensive icf core set for multiple sclerosis with participants referred for work ability assessment.

Valadkeviciene D, Jatuzis D, Zukauskaite I, Karrenbauer V, Bileviciute-Ljungar I J Rehabil Med. 2024; 56:jrm19671.

PMID: 38450443 PMC: 10938140. DOI: 10.2340/jrm.v56.19671.


Self-scored impairments in functioning and disability in post-COVID syndrome following mild COVID-19 infection.

Norrefalk J, Borg K, Bileviciute-Ljungar I J Rehabil Med. 2021; 53(11 (November)):jrm00239.

PMID: 34643243 PMC: 8638742. DOI: 10.2340/jrm.v53.188.


Determination of Multiple Sclerosis Indicators for Value-Based Contracting Using the Delphi Method.

Swart E, Neilson L, Good C, Shrank W, Henderson R, Manolis C J Manag Care Spec Pharm. 2019; 25(7):753-760.

PMID: 31232201 PMC: 10397620. DOI: 10.18553/jmcp.2019.25.7.753.


Self-assessment reliability in multiple sclerosis: the role of socio-demographic, clinical, and quality of life aspects.

Tacchino A, Brichetto G, Zaratin P, Battaglia M, Ponzio M Neurol Sci. 2018; 40(3):617-620.

PMID: 30291467 DOI: 10.1007/s10072-018-3589-6.


References
1.
McCabe M, McKern S, McDonald E . Coping and psychological adjustment among people with multiple sclerosis. J Psychosom Res. 2004; 56(3):355-61. DOI: 10.1016/S0022-3999(03)00132-6. View

2.
Roberts M, Wilkinson S, Diamond I, McLellan D, Martin J, Spackman A . The prevalence of cognitive impairment in a community survey of multiple sclerosis. Br J Clin Psychol. 1991; 30(4):333-48. DOI: 10.1111/j.2044-8260.1991.tb00954.x. View

3.
Sundstrom P, Svenningsson A, Nystrom L, Forsgren L . Clinical characteristics of multiple sclerosis in Västerbotten County in northern Sweden. J Neurol Neurosurg Psychiatry. 2004; 75(5):711-6. PMC: 1763583. DOI: 10.1136/jnnp.2003.012856. View

4.
Stevenson V, Playford E . Rehabilitation and MS. Int MS J. 2007; 14(3):85-92. View

5.
Stucki G, Grimby G . Applying the ICF in medicine. J Rehabil Med. 2004; (44 Suppl):5-6. DOI: 10.1080/16501960410022300. View